ÁNGEL
GIL HERNÁNDEZ
Ikertzailea 2023-(e)tik
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2007
-
Immunogenicity and safety of three doses of a bivalent (B : 4 : P1.19,15 and B : 4 : P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents
CLINICAL AND VACCINE IMMUNOLOGY, Vol. 14, Núm. 1, pp. 65-73